Veer Bhavnagri - Dec 15, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: General Counsel
Signature: /s/Veer Bhavnagri
Stock symbol: ALLO
Transactions as of: Dec 15, 2022
Transactions value $: -$42,186
Form type: 4
Date filed: 12/19/2022, 03:29 PM
Previous filing: Mar 25, 2022
Next filing: Jan 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Sale	-$42.2K	-5.6K	-0.95%	$7.53	584K	Dec 15, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Content

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.